Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Amling

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
AIDS Patient Care and Stds|February 1, 2007
Erectile dysfunction and hypogonadism among men with HIVNancy F Crum-Cianflone, Mary Bavaro, Braden Hale, et al.
JAMA Network Open|June 3, 2021
Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs CohortKristina Vaculik, Michael Luu, Lauren E Howard, et al.
The Journal of Urology|February 10, 2004
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
The Journal of Urology|April 25, 2008
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
Urologic Oncology|December 25, 2003
Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national databaseJudd W Moul, Leon Sun, Hongyu Wu, et al.
Urologic Oncology|March 15, 2024
Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance eraSanjay Das, Michael Luu, Martha Terris, et al.
Journal of Graduate Medical Education|January 10, 2014
Urology milestonesMichael Coburn, Christopher Amling, Robert R Bahnson, et al.
Prostate Cancer and Prostatic Diseases|June 6, 2022
Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomyMichelle S Chen, Lauren E Howard, Shannon Stock, et al.
The Journal of Urology|February 10, 2004
Watchful waiting and factors predictive of secondary treatment of localized prostate cancerHongyan Wu, Leon Sun, Judd W Moul, et al.
The Journal of Urology|April 11, 2003
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomyJason C Massengill, Leon Sun, Judd W Moul, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
AIDS Patient Care and Stds|February 1, 2007
Erectile dysfunction and hypogonadism among men with HIVNancy F Crum-Cianflone, Mary Bavaro, Braden Hale, et al.
JAMA Network Open|June 3, 2021
Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs CohortKristina Vaculik, Michael Luu, Lauren E Howard, et al.
The Journal of Urology|February 10, 2004
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
The Journal of Urology|April 25, 2008
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
Urologic Oncology|December 25, 2003
Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national databaseJudd W Moul, Leon Sun, Hongyu Wu, et al.
Urologic Oncology|March 15, 2024
Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance eraSanjay Das, Michael Luu, Martha Terris, et al.
Journal of Graduate Medical Education|January 10, 2014
Urology milestonesMichael Coburn, Christopher Amling, Robert R Bahnson, et al.
Prostate Cancer and Prostatic Diseases|June 6, 2022
Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomyMichelle S Chen, Lauren E Howard, Shannon Stock, et al.
The Journal of Urology|February 10, 2004
Watchful waiting and factors predictive of secondary treatment of localized prostate cancerHongyan Wu, Leon Sun, Judd W Moul, et al.
The Journal of Urology|April 11, 2003
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomyJason C Massengill, Leon Sun, Judd W Moul, et al.
Pageof 3